Pharma Journalist - Page 654 of 835 -

Zai Lab’s ZL-1310 Earns FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment

Cellipont Bioservices to Manufacture Master Cell Bank for Secretome Therapeutics’ Lead Asset STM-01

Glox Therapeutics Secures Share of £3M Funding to Combat Antibiotic Resistance in Cystic Fibrosis

Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

AbbVie Submits Application to EMA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis

Bavarian Nordic receives FDA Orphan Drug Designation for BN-Brachyury for the treatment of Chordoma

Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

5 Benefits of Risk-Based Monitoring (RBM) Within Clinical Trials

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens

Cirius Therapeutics Reaches Enrollment Target in Phase 2b EMMINENCE Trial in NASH

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug

ACADIA Pharma Announces Appointment of Elena Ridloff as SVP, Investor Relations